长非编码RNAs:在胰腺癌中侵入和转移的新兴调节者
Mengmeng Shi1, Rui Zhang1, Hao Lyu1
1National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan 430068, China.
Journal of advanced research
|February 11, 2025
概括
长非编码RNAs (lncRNAs) 通过调节上皮细胞-介质细胞过渡 (EMT) 和其他分子通路,显著推动胰腺癌的侵袭和转移. 了解lncRNA的作用为新型诊断和治疗提供了潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 胰腺癌 (PC) 侵袭和转移对于预后不佳至关重要.
- 长非编码RNAs (lncRNAs) 作为关键的调节器而出现的表皮细胞-介质细胞过渡 (EMT) 是一个关键的驱动因素.
- lncRNA对转移的影响超出了EMT的范围,涉及复杂的分子机制.
研究的目的:
- 描述参与胰腺癌入侵和转移的lncRNAs.
- 总结IncRNA在多个分子途径中的调节作用.
- 突出 lncRNAs 在诊断和治疗中临床应用的翻译潜力.
主要方法:
- 在胰腺癌转移中 lncRNAs 的文献综述.
- 对lncRNA参与EMT相关信号通路的分析 (例如TGF-β/Smad,Wnt/β-catenin,Notch).
- 检查lncRNA在自,铁和瘤微环境中的作用,包括外体lncRNA.
- 研究影响lncRNA稳定性和功能的RNA修饰 (m6A,m5C).
主要成果:
- lncRNAs调节与EMT相关的信号通路,增强细胞运动性和侵入性.
- lncRNAs影响自和铁,外体 lncRNAs调节瘤微环境以促进入侵.
- 像m6A和m5C这样的RNA修饰稳定了lncRNAs,增强了它们在转移中的作用.
- 尽管面临挑战,lncRNAs作为生物标志物和治疗点具有前景.
结论:
- lncRNAs是胰腺癌入侵和转移的多方面的调节者.
- 准lncRNAs并了解它们的修饰提供了潜在的治疗策略.
- 需要进行进一步的研究,以克服基于 lncRNA 的诊断和治疗的临床翻译方面的挑战.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K


